Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

BACKGROUND: Trabectedin has shown efficacy against soft tissue sarcomas (STS) and has manageable toxicity. Trabectedin is administered through central venous access devices (VAD), such as subcutaneous ports with tunneled catheters, Hickman catheters and PICC lines. Venous access related adverse even...

詳細記述

保存先:
書誌詳細
出版年:Clin Sarcoma Res
主要な著者: Verboom, Michiel C., Ouwerkerk, Jan, Steeghs, Neeltje, Lutjeboer, Jacob, Martijn Kerst, J., van der Graaf, Winette T. A., Reyners, Anna K. L., Sleijfer, Stefan, Gelderblom, Hans
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282803/
https://ncbi.nlm.nih.gov/pubmed/28163887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-017-0066-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料